No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Treatment with empagliflozin reduced progression of chronic kidney disease

byZain Cheema

May 2, 2023

in StudyGraphics

Reading Time: 1 min read

#VisualAbstract: Treatment with empagliflozin reduced progression of chronic kidney disease

Treatment with semaglutide in patients with obesity may be associated with weight loss

RelatedReports

Type 2 diabetes associated with reduction in disability-free life years

Endocrinology

Swedish study reports low vision loss risk with GLP-1RAs

July 13, 2026

Intrapartum serum prolactin may predict risk of postpartum diabetes

Endocrinology

GLP-1RAs may increase ischemic optic neuropathy risk

July 13, 2026

Endocrinology

GLP-1RAs showed no advantage for basal insulin discontinuation

July 13, 2026

Fish oil and aspirin did not reduce arteriovenous fistula failure: The FAVOURED trail

Chronic Disease

An intradialytic exercise intervention did not improve dialysis adequacy

May 18, 2026

Radiation dose associated with increased heart disease in Hodgkin lymphoma survivors

Optimal implementation of sodium-glucose cotransporter-2 inhibitors in US patients with heart failure estimated to cause a significant reduction in worsening heart failure events over 3 years

Initial thoracic endovascular aortic repair not associated with reduced mortality and morbidity compared to medical therapy for acute uncomplicated type B aortic dissection

Quick Take: Intravenous patient-controlled analgesia versus thoracic epidural analgesia after open liver surgery

2 Minute Medicine Rewind November 14, 2022

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

#VisualAbstract: Treatment with empagliflozin reduced progression of chronic kidney disease

Swedish study reports low vision loss risk with GLP-1RAs

GLP-1RAs may increase ischemic optic neuropathy risk

GLP-1RAs showed no advantage for basal insulin discontinuation

Treatment with semaglutide in patients with obesity may be associated with weight loss

Optimal implementation of sodium-glucose cotransporter-2 inhibitors in US patients with heart failure estimated to cause a significant reduction in worsening heart failure events over 3 years

RelatedReports

Swedish study reports low vision loss risk with GLP-1RAs

GLP-1RAs may increase ischemic optic neuropathy risk

GLP-1RAs showed no advantage for basal insulin discontinuation

An intradialytic exercise intervention did not improve dialysis adequacy

Optimal implementation of sodium-glucose cotransporter-2 inhibitors in US patients with heart failure estimated to cause a significant reduction in worsening heart failure events over 3 years

Initial thoracic endovascular aortic repair not associated with reduced mortality and morbidity compared to medical therapy for acute uncomplicated type B aortic dissection

2 Minute Medicine Rewind November 14, 2022

2MM+ All Access

Recent Reports

The medical literature, distilled daily.

Membership benefits

#VisualAbstract: Treatment with empagliflozin reduced progression of chronic kidney disease

RELATED REPORTS

Treatment with semaglutide in patients with obesity may be associated with weight loss

Optimal implementation of sodium-glucose cotransporter-2 inhibitors in US patients with heart failure estimated to cause a significant reduction in worsening heart failure events over 3 years

RelatedReports

2MM+ All Access

Recent Reports

The medical literature, distilled daily.

Membership benefits